Cargando…
Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has been suggested as a treatment option for severe CRSwNP....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502990/ https://www.ncbi.nlm.nih.gov/pubmed/36143311 http://dx.doi.org/10.3390/jpm12091526 |
_version_ | 1784795852680724480 |
---|---|
author | Ottaviano, Giancarlo Saccardo, Tommaso Roccuzzo, Giuseppe Bernardi, Riccardo Chicco, Alessandra Di Pendolino, Alfonso Luca Scarpa, Bruno Mairani, Edoardo Nicolai, Piero |
author_facet | Ottaviano, Giancarlo Saccardo, Tommaso Roccuzzo, Giuseppe Bernardi, Riccardo Chicco, Alessandra Di Pendolino, Alfonso Luca Scarpa, Bruno Mairani, Edoardo Nicolai, Piero |
author_sort | Ottaviano, Giancarlo |
collection | PubMed |
description | Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has been suggested as a treatment option for severe CRSwNP. Methods: Patients with severe CRSwNP receiving dupilumab from January 2021 were followed up at 1, 3, 6, 9 and 12 months from the first administration and were considered for this study. At baseline and at each follow-up, patients underwent nasal endoscopy and completed the Sinonasal Outcome Test (SNOT)-22, a Visual Analogue Scale (VAS) for smell/nasal obstruction, the Nasal Congestion Score and the Asthma Control Test. Peak nasal inspiratory flow (PNIF), a smell test, nasal cytology and blood eosinophilia were also evaluated. Results: Forty-seven patients were included in the study. Of these, 33 patients had a history of previous surgery (ESS) and had recurrent nasal polyps, while 14 patients were naïve to nasal surgery. Both subjective and objective parameters improved after biological treatment and were correlated with each other (p < 0.05), except for the SNOT-22 and the nasal polyp’s score. No correlations were found between nasal and blood eosinophilia. No differences were observed when comparing the post-surgical and the naïve groups. Conclusions: Dupilumab improves nasal obstruction and the sense of smell and reduces the level of local inflammation in severe CRSwNP patients in a similar way in both naïve and post-surgical patients. |
format | Online Article Text |
id | pubmed-9502990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95029902022-09-24 Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients Ottaviano, Giancarlo Saccardo, Tommaso Roccuzzo, Giuseppe Bernardi, Riccardo Chicco, Alessandra Di Pendolino, Alfonso Luca Scarpa, Bruno Mairani, Edoardo Nicolai, Piero J Pers Med Article Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) represents 25–30% of all CRS cases, and in the most severe forms it is associated with a poor quality of life and a high rate of nasal polyps’ recurrence after surgery. Dupilumab has been suggested as a treatment option for severe CRSwNP. Methods: Patients with severe CRSwNP receiving dupilumab from January 2021 were followed up at 1, 3, 6, 9 and 12 months from the first administration and were considered for this study. At baseline and at each follow-up, patients underwent nasal endoscopy and completed the Sinonasal Outcome Test (SNOT)-22, a Visual Analogue Scale (VAS) for smell/nasal obstruction, the Nasal Congestion Score and the Asthma Control Test. Peak nasal inspiratory flow (PNIF), a smell test, nasal cytology and blood eosinophilia were also evaluated. Results: Forty-seven patients were included in the study. Of these, 33 patients had a history of previous surgery (ESS) and had recurrent nasal polyps, while 14 patients were naïve to nasal surgery. Both subjective and objective parameters improved after biological treatment and were correlated with each other (p < 0.05), except for the SNOT-22 and the nasal polyp’s score. No correlations were found between nasal and blood eosinophilia. No differences were observed when comparing the post-surgical and the naïve groups. Conclusions: Dupilumab improves nasal obstruction and the sense of smell and reduces the level of local inflammation in severe CRSwNP patients in a similar way in both naïve and post-surgical patients. MDPI 2022-09-17 /pmc/articles/PMC9502990/ /pubmed/36143311 http://dx.doi.org/10.3390/jpm12091526 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ottaviano, Giancarlo Saccardo, Tommaso Roccuzzo, Giuseppe Bernardi, Riccardo Chicco, Alessandra Di Pendolino, Alfonso Luca Scarpa, Bruno Mairani, Edoardo Nicolai, Piero Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title | Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title_full | Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title_fullStr | Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title_full_unstemmed | Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title_short | Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients |
title_sort | effectiveness of dupilumab in the treatment of patients with uncontrolled severe crswnp: a “real-life” observational study in naïve and post-surgical patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502990/ https://www.ncbi.nlm.nih.gov/pubmed/36143311 http://dx.doi.org/10.3390/jpm12091526 |
work_keys_str_mv | AT ottavianogiancarlo effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT saccardotommaso effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT roccuzzogiuseppe effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT bernardiriccardo effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT chiccoalessandradi effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT pendolinoalfonsoluca effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT scarpabruno effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT mairaniedoardo effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients AT nicolaipiero effectivenessofdupilumabinthetreatmentofpatientswithuncontrolledseverecrswnpareallifeobservationalstudyinnaiveandpostsurgicalpatients |